AVNS Avanos Medical Inc

Price (delayed)

$19.56

Market cap

$897.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.33

Enterprise value

$1.04B

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights
The quick ratio has declined by 33% year-on-year but it has increased by 3.1% since the previous quarter
Avanos Medical's debt has decreased by 16% YoY but it has increased by 2.7% from the previous quarter
The company's equity fell by 5% YoY
The gross profit has contracted by 3.3% YoY

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
45.9M
Market cap
$897.88M
Enterprise value
$1.04B
Valuations
Price to book (P/B)
0.74
Price to sales (P/S)
1.33
EV/EBIT
N/A
EV/EBITDA
493.7
EV/Sales
1.52
Earnings
Revenue
$680.1M
EBIT
-$43.3M
EBITDA
$2.1M
Free cash flow
$13.3M
Per share
EPS
-$1.33
Free cash flow per share
$0.29
Book value per share
$26.58
Revenue per share
$14.72
TBVPS
$13.71
Balance sheet
Total assets
$1.66B
Total liabilities
$433.4M
Debt
$214.7M
Equity
$1.23B
Working capital
$262.6M
Liquidity
Debt to equity
0.17
Current ratio
2.28
Quick ratio
1.01
Net debt/EBITDA
66.14
Margins
EBITDA margin
0.3%
Gross margin
56.3%
Net margin
-9.1%
Operating margin
3.9%
Efficiency
Return on assets
-3.7%
Return on equity
-5.1%
Return on invested capital
-6.9%
Return on capital employed
-3%
Return on sales
-6.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
0.57%
1 week
1.66%
1 month
-3.6%
1 year
-23.62%
YTD
-12.8%
QTD
-1.76%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$680.1M
Gross profit
$383.1M
Operating income
$26.6M
Net income
-$62.2M
Gross margin
56.3%
Net margin
-9.1%
The operating income has soared by 52% QoQ but it is down by 29% YoY
Avanos Medical's operating margin has soared by 50% from the previous quarter but it has decreased by 29% YoY
The gross profit has contracted by 3.3% YoY
The gross margin has declined by 2.8% year-on-year

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
P/E
N/A
P/B
0.74
P/S
1.33
EV/EBIT
N/A
EV/EBITDA
493.7
EV/Sales
1.52
AVNS's price to book (P/B) is 38% less than its 5-year quarterly average of 1.2 and 8% less than its last 4 quarters average of 0.8
The company's equity fell by 5% YoY
The P/S is 40% lower than the 5-year quarterly average of 2.2 and 11% lower than the last 4 quarters average of 1.5

Efficiency

How efficient is Avanos Medical business performance
AVNS's ROIC has plunged by 179% YoY
The ROS has plunged by 170% YoY but it has grown by 4.5% from the previous quarter
The return on assets has declined by 2.8% since the previous quarter
The ROE has contracted by 2% from the previous quarter

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
The quick ratio has declined by 33% year-on-year but it has increased by 3.1% since the previous quarter
The company's current ratio fell by 20% YoY but it rose by 10% QoQ
Avanos Medical's debt is 83% less than its equity
Avanos Medical's debt has decreased by 16% YoY but it has increased by 2.7% from the previous quarter
The debt to equity has contracted by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.